SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-091489
Filing Date
2020-08-06
Accepted
2020-08-06 16:48:33
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tm2026741-1_s3.htm S-3 312680
2 EXHIBIT 5.1 tm2026741d2_ex5-1.htm EX-5.1 8713
3 EXHIBIT 5.2 tm2026741d2_ex5-2.htm EX-5.2 8087
4 EXHIBIT 23.1 tm2026741d2_ex23-1.htm EX-23.1 3425
5 GRAPHIC tm2026741d2_ex5-1img001.jpg GRAPHIC 7581
6 GRAPHIC tm2026741d2_ex5-1img002.jpg GRAPHIC 5466
7 GRAPHIC tm2026741d2_ex5-2img001.jpg GRAPHIC 2992
8 GRAPHIC lg_entasis-4clr.jpg GRAPHIC 432899
9 GRAPHIC tm2026741d1-tbl_program4clr.jpg GRAPHIC 2512749
  Complete submission text file 0001104659-20-091489.txt   4409236
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-241683 | Film No.: 201082424
SIC: 2834 Pharmaceutical Preparations